Joao L Cavalcante
Overview
Explore the profile of Joao L Cavalcante including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
195
Citations
2548
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khalique O, Zaid S, Tang G, Abdel-Wahab M, Akodad M, Bapat V, et al.
J Am Coll Cardiol
. 2025 Mar;
85(10):1042-1055.
PMID: 40074470
This updated Heart Valve Collaboratory framework addresses the growing concern for transcatheter valve failure (TVF) following transcatheter aortic valve replacement (TAVR). With the increasing volume of redo-TAV and surgical TAV...
2.
Guddeti R, Garg P, Kereiakes D, Cavalcante J, Carlsson M, Garcia S
J Soc Cardiovasc Angiogr Interv
. 2025 Mar;
4(1):102439.
PMID: 40061421
Elevation in left atrial pressure with subsequent pulmonary congestion is central to the pathology of heart failure. Interatrial shunts have emerged as a potential therapeutic strategy in patients with heart...
3.
Idris A, Hurreh M, Knickelbine T, Cavalcante J, Lesser J, Miedema M, et al.
Int J Cardiovasc Imaging
. 2025 Feb;
PMID: 40019592
Differentiating normal from minimally and mildly diseased coronary arteries on coronary computed tomographic angiography (CCTA) is crucial, impacting treatment decisions due to the extremely low coronary artery event risk associated...
4.
Neethling W, Forster G, Meduri C, Meuris B, Asgar A, Sellers S, et al.
Front Cardiovasc Med
. 2025 Feb;
12:1512961.
PMID: 39991635
Introduction: Clinical evidence highlighting the efficacy and safety of transcatheter aortic valve replacement (TAVR) and the 2019 Food and Drug Administration (FDA) approval for TAVR in low-risk (younger) patients has...
5.
Kwak S, Singh A, Everett R, Treibel T, Lim J, Won S, et al.
JAMA Cardiol
. 2025 Feb;
PMID: 39969863
Importance: Myocardial fibrosis in aortic stenosis (AS) may exhibit sex differences. However, its prognostic significance in women with AS remains unclear. Objective: To investigate sex differences in myocardial fibrosis assessed...
6.
Lorenzatti D, Filtz A, Geers J, Grodecki K, Jaspan V, Pierce C, et al.
J Cardiovasc Comput Tomogr
. 2025 Feb;
PMID: 39915136
In an era of rapidly expanding use of transcatheter aortic valve replacement (TAVR), cardiovascular computed tomography (CCT) has become an essential component in the evaluation process for the growing number...
7.
Fisher G, Okeson B, Walser-Kuntz E, Cavalcante J, Traverse J
Eur Heart J Open
. 2025 Feb;
5(1):oeaf002.
PMID: 39912103
No abstract available.
8.
Carvalho P, Cavalcante J, Lesser J, Cheng V, Strepkos D, Alexandrou M, et al.
JACC Case Rep
. 2025 Jan;
30(2):102814.
PMID: 39886416
Coronary computed tomography angiography (CTA) analysis can help in the planning of percutaneous coronary intervention (PCI). Fractional flow reserve derived from coronary CTA (FFR), coronary CTA-derived regional myocardial mass, and...
9.
Parekh J, Burns M, Hamid N, Helmy T, Bapat V, Cavalcante J, et al.
JACC Case Rep
. 2025 Jan;
30(2):102767.
PMID: 39886395
We present a first in human experience of transseptal balloon-assisted translocation of a mitral anterior leaflet (BATMAN) to facilitate transcatheter mitral valve replacement in a patient with severe mitral annular...
10.
Carvalho P, Cavalcante J, Cheng V, Lesser J, Brilakis E, Sandoval Y
JACC Cardiovasc Interv
. 2025 Jan;
18(2):260-262.
PMID: 39880578
No abstract available.